SciSight Ecosystem
WoS SCIE Q4Scopus Q3SCImago #13,588CAS 4区Gold OA

Journal of Cancer Research and Therapeutics

Abbreviation (ISO):J. Cancer Res. Ther
Country: India•WoS SCIE Quartile: Q4•Scopus SJR: 0.425•SCImago Rank: #13,588•Identifier (ISSN):0973-1482(Print)/0974-1127(Online)•Articles / Year: 252•Estimated Publication Fee (APC): $2,821 USD
Clarivate IF (2026)Q4
1.4
↑ +0.1

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
30

30 papers with at least that number of citations each

WoS: SCIE / JCRQ4
Self-Citation Rate21.4%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
252articles/year
100% Gold OA•91.03% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.00pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q4(IF: 1.4)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20261.00đ
WoS Q4(IF: 1.4)
🔵 Computed
20251.00đ
WoS Q4(IF: 1.3)
🔵 Computed
20241.00đ
WoS Q4(IF: 1.4)
🔵 Computed
20231.00đ
WoS Q4(IF: 1.3)
🔵 Computed
20221.00đ
WoS Q4(IF: 1.331)
🔵 Computed
20211.00đ
WoS Q4(IF: 1.805)
🔵 Computed
20201.00đ
WoS Q4(IF: 1.326)
🔵 Computed
20191.00đ
WoS Q4(IF: 1.392)
🔵 Computed
20181.00đ
WoS Q4(IF: 0.842)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

The journal will cover technical and clinical studies related to health, ethical and social issues in field of Medical oncology, radiation oncology, medical imaging, radiation protection, non-ionising radiation, radiobiology. Articles with clinical interest and implications will be given preference.

Topics Covered (Recognized by AI)
Medicine97%Internal medicine90.1%Biology89.4%Genetics79.9%Pathology67.3%Surgery61%Cancer56.2%Radiology47.5%Chemistry40.4%Oncology35.7%Biochemistry34%Immunology29.2%Mathematics25.3%Cancer research23%Radiation therapy22.9%Physics20.6%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #13,588Scopus Q3SCImago Profile
Scopus Coverage:2005-2025
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q3
0.425

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q3
Scopus H-Index (2025)
58

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
1.29

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,821 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations1,730
3-Year Documents1,312
Citable Documents1,261

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate39.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q3
OncologyQ3
Radiology, Nuclear Medicine and ImagingQ3

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Gold OA
OA publishing option or traditional subscription
Publisher
Wolters Kluwer Medknow Publications
Publication Language
English
Frequency
Quarterly
Editorial Address
MEDKNOW PUBLICATIONS, A-108-109 KANARA BUSINESS CENTRE, GHAKTOPAR, MUMBAI, INDIA, 400075
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
ONCOLOGY
JCRSCIE
287/333Q4
ONCOLOGY
JCISCIE
291/333Q4

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—919
20251.3237211
20241.4247632
20231.35251,907
20221.3314742,282
20211.8052881,940
20201.3263122,766
20191.3922483,177
20180.8426637,514
2017—3043,850
2016—3655,490
2015—5264,767
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Journal of Cancer Research and Therapeutics

WoS Q4
0123201820192020202120222023202420251.30
Annual Impact Factor Metric
2025:1.3

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 21.4%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 4067c8e5-5431-4bbe-b93e-5ea8d8dfbabc
Database Updated: 2026-09-29